Symphony Medical, Inc., develops proprietary biopolymer and cellular-based biologic therapies to effectively treat chronic and post-operative atrial fibrillation and heart failure.

More about the Company

Symphony Medical has matched significant clinical and scientific resources in cardiology and electrophysiology with a proprietary portfolio of biopolymers, cell therapies, biotherapeutics, and surgical or catheter-based delivery devices.

Explore our products

Explore our technologies